Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jun 21, 2008; 14(23): 3672-3680
Published online Jun 21, 2008. doi: 10.3748/wjg.14.3672
Published online Jun 21, 2008. doi: 10.3748/wjg.14.3672
Figure 6 Ellagic acid decreases the activity of the transcription factor NF-κB.
The effects of ellagic acid and pharmacological or molecular inhibition of NF-κB on apoptosis are not additive. MIA PaCa-2 (A and B) cells were cultured for 48 h in the presence or absence of indicated doses of ellagic acid. MIA PaCa-2 cells were transfected with 4KBwt-pRL-TK luciferase plasmid and pRL-TK luciferase as a control using the NucleofectorTM II electroporation system(C and D). A: NF-κB binding activity was measured as described in Experimental procedures; B and D: Internucleosomal DNA fragmentation was measured using the Cell Death Detection ELISA kit; C: NF-κB transcriptional activity was assessed using the dual-Luciferase Reporter Assay System assay. Results are representative of at least 3 independent experiments. Values are normalized to control (B and D). Values are mean ± SE (n = 3), aP < 0.05 vs control.
- Citation: Edderkaoui M, Odinokova I, Ohno I, Gukovsky I, Go VLW, Pandol SJ, Gukovskaya AS. Ellagic acid induces apoptosis through inhibition of nuclear factor κB in pancreatic cancer cells. World J Gastroenterol 2008; 14(23): 3672-3680
- URL: https://www.wjgnet.com/1007-9327/full/v14/i23/3672.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.3672